[1,3]diazino[5,4-d]pyrimidines as HER2 inhibitors
AU2026220268A1Pending Publication Date: 2026-09-10BOEHRINGER INGELHEIM INT GMBH
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- AU2026220268
- Authority / Receiving Office
- AU · AU
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2026-08-21
- Publication Date
- 2026-09-10
Abstract
[l,3]DIAZINO[5,4-d]PYRIMIDINES AS HER2 INHIBITORS Abstract The present invention relates to new [1,3]diazino[5,4-d]pyrimidines and derivatives of Formula (I), wherein the groups R1, R2, R3 and R4 have the meanings given in the claims and specification, their use as inhibitors of HER2 and its mutants, pharmaceutical compositions which contain such compounds and their use as medicaments, especially as agents for treatment and / or prevention of oncological diseases. R 0 RX 3 HN R² R N. N N. N (I) diseases. 20 26 22 02 68 21 A ug 2 02 6 2 0 2 6 2 2 0 2 6 8 2 1 2 0 2 6 A u g A b s t r a c t R 0 H N R ² R N N . N
Need to check novelty before this filing date? Find Prior Art
